Drugs / MCS®
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT02042807 Comparator | Oct 2014 → Dec 2024 | prostate cancer | Health Ever Bio-Tech Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MCS | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02042807 ↗ |